Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 71, 6-12
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- AIEOP‐BFMConsensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic LeukemiaCytometry Part B: Clinical Cytometry, 2017
- Acute Megakaryoblastic Leukemia Associated with Trisomy 21 Demonstrates a Distinct ImmunophenotypeCytometry Part B: Clinical Cytometry, 2014
- Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndromeCytometry Part B: Clinical Cytometry, 2013
- The earliest thymic T cell progenitors sustain B cell and myeloid lineage potentialNature Immunology, 2012
- A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid‐based modelImmunological Reviews, 2010
- Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendationsBritish Journal of Haematology, 2010
- A new paradigm for hematopoietic cell lineages: revision of the classical concept of the myeloid–lymphoid dichotomyTrends in Immunology, 2009
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangementLeukemia, 2007
- New Evidence Supporting Megakaryocyte-Erythrocyte Potential of Flk2/Flt3+ Multipotent Hematopoietic ProgenitorsCell, 2006